CompoAtlas

TMG

Food supplement declared in France, decision dated 30 October 2026

TMG (MOLEQLAR) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition.

Brand
MOLEQLAR
Food business operator placing the product on the market
MoleQlar GmbH
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
2
Intended populations
Men and women aged 18 and over
Not recommended (according to the manufacturer)
Breastfeeding women, Pregnant women
Objectives stated by the manufacturer (these are not authorised claims)
Sport

Declaration 380988, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Substances

NamePer day
bétaïne400 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • bétaïne
    Read the warning, when it applies and the studies cited

    BETAINE / BETAINE HYDROCHLORIDE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Applies to products containing Betaine hydrochloride (as a medicinal ingredient or as a source ingredient).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a peptic ulcer or excess stomach acid (RSC 2024; Hendler and Rorvik 2008).

    Sources cited by Health Canada (2)
    • Hendler SS, Rorvik DM. PDR® for Nutritional Supplements, 2nd edition. Thomson Reuters. Physicians' Desk References Inc., NJ; 2008.
    • RSC 2024: Royal Society of Chemistry: The Merck Index Online [Accessed 2024 June 20]. Available from: https://merckindex.rsc.org/

    Applies to products providing 600 milligrams or more of Betaine or 780 milligrams or more of Betaine hydrochloride as a medicinal ingredient, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have high cholesterol (Olthof et al. 2005; Swab et al. 2002).

    Sources cited by Health Canada (2)
    • Olthof MR, van Vliet T, Verhoef P, Zock PL, Katan MB. Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in health humans. PLoS Medicine 2005;2(5):e135. PubMed Randomised trial
    • Swab U, Torronen A, Toppinen L, Alfthan G, Saarinen M, Aro A, Uusitupa M. Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. American Journal of Clinical Nutrition 2002;76:961-967.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : MOLEQLAR

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line